A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Canagliflozin in Older Children and Adolescents with Type 2 Diabetes Mellitus

Update Il y a 4 ans
Reference: EUCTR2013-005455-32

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this study is to evaluate the pharmacokinetics of canagliflozin after multiple oral doses of canagliflozin in children and adolescent subjects with T2DM who are 10 to <18 years of age and are currently taking a stable dose of metformin.


Inclusion criteria

  • Patients with type 2 diabetes mellitus (T2DM) on a stable dose of Metformin (receiving standard of care)

Links